Product NDC: | 55154-2722 |
Proprietary Name: | Geodon |
Non Proprietary Name: | ziprasidone mesylate |
Active Ingredient(s): | 20 mg/mL & nbsp; ziprasidone mesylate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-2722 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020919 |
Marketing Category: | NDA |
Start Marketing Date: | 20031223 |
Package NDC: | 55154-2722-5 |
Package Description: | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-2722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55154-2722-5 |
Proprietary Name | Geodon |
Package Description | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-2722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55154-2722 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ziprasidone mesylate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20031223 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | ZIPRASIDONE MESYLATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |